Table 2. Proportions of the various pharmacological and non-pharmacological treatments in patients with prevalent ADHD in 2023.

	Children/adolescents (< 18 years)	Adults (≥ 18 years)	Total
No treatment (no pharmacotherapy, no psychotherapy)	40.9%	44.4%	42.5%
Pharmacotherapy only (no psychotherapy)	47.8%	38.0%	43.2%
Psychotherapy only (no pharmacotherapy)	4.2%	7.6%	5.8%
Behavioral therapy only (subcategory of “Psychotherapy only → no pharmacotherapy”)	2.1%	4.7%	3.3%
Multimodal treatment (pharmacotherapy + psychotherapy)	7.1%	10.0%	8.4%
Occupational therapy (regardless of other treatment modalities)	22.4%	3.5%	13.5%

Only the treatment patterns shown here apply; other treatment modalities not listed here are not included.

ADHD, attention-deficit/hyperactivity disorder